Medtec is a specialized exhibition dedicated to delivering solutions for medical device R&D and manufacturing. Its 20th edition will take place from September 1-3, 2026, and will relocate to a new venue: SNIEC (Pudong) N1-N4.
Visitor Badge can be applied in March 2026, the pre-registration is for free while the ticket will cost ￥100 onsite from September 1 to 3.
Background:
Currently, the nation is intensifying the implementation of an innovation-driven development strategy, with a focus on cultivating new quality productive forces. A series of policies have been introduced, such as the 2026 Government Work Report and the Several Opinions on Accelerating the High-Quality Development of Science and Technology Insurance to Strongly Support High-Level Self-Reliance in Science and Technology. These initiatives aim to enhance incentives for university technology transfer, promote the deep integration of innovation chains, industrial chains, capital chains, and talent chains, and facilitate the transition of academic research from laboratories to industrial applications. This effectively transforms the advantages of the patent system into dynamic drivers for innovative development. Universities, possessing abundant high-quality research resources, serve as the cradle of original innovation and the supplier of core technologies. . However, the contradiction between “high research output” and “low commercialization activity” remains prominent. There is an urgent need to establish efficient docking platforms to address bottlenecks in technology transfer. The University Innovation Academic Forum focuses on the transformation of academic achievements, bringing together diverse stakeholders to establish a high-end platform for academic exchange, achievement showcase, and collaboration. It aims to precisely align university research outcomes with industrial needs, foster synergy between academic innovation and industrial development, and contribute to self-reliance and high-quality development in science and technology.
Participants:
- Relevant upstream and downstream enterprises in the medical device industry
- Scholars from universities and research institutions: researchers, technology transfer officers, academic leaders
- Clinicians: Physicians in various clinical fields, medical researchers, and heads of scientific research at medical institutions
- Relevant investment and financing representatives and other institutions
- Other professionals interested in university technology transfer and related technical fields who are open to collaboration
Agenda:
| Time | Topic |
| 13:50-14:00 | Moderator Remarks |
| 14:00-14:30 | Applications of Optical Imaging Technology in Disease Diagnosis |
| 14:30-15:00 | Confocal Microscopy Endoscopy Technology |
| 15:00-15:30 | Applications of Photonic Technology in Medical Optical Diagnostic and Therapeutic Equipment |
| 15:30-16:00 | Integration of AI and Photonics Technology |
| 16:00-16:10 | Conference Close |
Background:
Implantable and interventional medical devices, which act as a pivotal growth impetus within the healthcare industry, are indispensable for treating critically ill patients, prolonging their lifespans, and enhancing their overall quality of life. Given their exceptionally high technological complexity and precision demands, the R&D design proficiency and clinical translation efficacy of the final products directly shape the industry’s fundamental competitiveness and the trajectory of domestic substitution. Currently, the industry is transitioning towards high-quality development, with R&D design and clinical translation emerging as the core drivers of industrial upgrading. Focusing on cutting-edge development and efficient translation of finished medical devices is a pivotal strategy to overcome industry bottlenecks and secure a leading position in the sector.
This forum aligns with industry hotspots, focusing on the most discussed finished products. It convenes top-tier industry resources to delve into the core technologies of product R&D, key clinical adaptation points, and commercialization pathways. The event aims to propel active and passive implantable/interventional devices from “lab design” to “clinical adoption,” assisting domestic implantable/interventional products in breaking through technical barriers and achieve localization substitution, thereby driving high-quality industry development.
Participants:
- Manufacturers of Implantable and Interventional Devices: R&D, Technical Departments, and Project/Corporate Leaders
- Supporting service suppliers for implantable and interventional devices
- Design service providers from sectors such as industrial design, design consulting, etc.
- Clinicians, universities and research institutes
Agenda:
| Time | Topic |
| 13:50-14:00 | Moderator Remarks |
| 14:00-14:30 | Artificial Heart: Miniaturized Design and Clinical Translation |
| 14:30-15:00 | Leadless Design and Clinical Compatibility of Implantable Cardioverter Defibrillators (ICDs) |
| 15:00-15:30 | Intervention Without Implantation: Innovative Breakthroughs and Clinical Applications of Drug-Coated Balloons |
| 15:30-16:00 | Structural Optimization and Intracranial Application of Flow Diverter Stents |
| 16:00-16:10 | Conference Close |
Background:
Under the dual impetus of the Healthy China strategy and an aging population, China’s in vitro diagnostics (IVD) and early disease screening industry have entered a critical period of technological innovation and landscape transformation. The industry is swiftly transitioning from traditional biochemical, immunological, and molecular diagnostics to more advanced, miniaturized, intelligent, and non-invasive solutions. The threshold for early screening continues to move forward, while the demand for precision diagnostics becomes increasingly pressing.
Currently, the domestic IVD industry is advancing the in-depth substitution of imported products, while normalized centralized procurement is driving the sector to break through with innovation and high-end solutions. Collaboration among industry, academia, research, and healthcare has become the mainstream approach for technology transformation. Emerging technologies such as organoid disease modeling, highly integrated and miniaturized lab-on-a-chip platforms, AI-assisted imaging diagnostic systems, and nano-microneedles are transcending the limitations of traditional diagnostics, emerging as pivotal forces in pioneering new early screening scenarios and boosting diagnostic efficiency.
To facilitate the transition of cutting-edge technologies from the laboratory to clinical settings and to close the loop of innovation translation, clinical application, and industrial ecosystem development, this forum centers on the integration and innovation of these emerging technologies. It convenes industry experts, enterprises, and clinical institutions to delve into technological pathways, implementation challenges, and future trends, thereby fostering high-quality development in China’s IVD and early disease screening industry.
Participants:
- Medical device manufacturers: heads of the departments of R&D, design, and technology, as well as project/company leaders.
- IVD and related equipment suppliers and service providers
- Clinicians, universities and research institutes
- Other professionals interested in the IVD (In Vitro Diagnostics) and early disease screening industry
Agenda:
| Time | Topic |
| 9:50-10:00 | Moderator Remarks |
| 10:00-10:30 | Organoid Chip Technology Empowers Clinical Early Screening |
| 10:30-11:00 | Large‑Scale Application of Biochips in Early Screening |
| 11:00-11:30 | Optimization of Pump Systems in Fully Automatic Chemiluminescence Early Screening Analyzers To Be Invited: Shenzhen Megaron Group Co., Ltd. |
| 11:30-12:00 | Dual Labeling of Colloidal Gold and Fluorescence: A Novel Strategy for Enhancing Sensitivity in POCT Early Screening To Be Invited: Genrui Biotech Inc. |
| 12:00-12:10 | Conference Close |
Background:
The prevention and treatment of cardiovascular diseases and the control of neurological disorders, along with the management of neurological disorders, represent two pivotal areas of human health, with a continuously growing clinical demand.
The cardiovascular field, centered on the heart and systemic vascular system, encompasses prevalent conditions such as coronary artery disease, arrhythmia, hypertension, and heart failure. With the intensification of population aging, clinical demands for cardiac interventional therapy, electrophysiological ablation, and implantable device replacements have surged. The neurological domain encompasses the brain, spinal cord, and peripheral nervous system, involving diverse conditions like stroke, neurodegenerative diseases, neurocritical care, and functional rehabilitation. Under scenarios of chronic disease management, brain function restoration, and neuromodulation, clinical necessities continue to expand.
Currently, innovation in the cardiovascular sector focuses on cardiac surgical robots, precision implantable/interventional devices, and non-invasive hemodynamic equipment, requiring deep alignment with clinical scenarios such as cardiac intervention and electrophysiology therapy. In the neurological field, innovation aims for breakthroughs in neuromodulation devices, brain functional imaging systems, neurorehabilitation aids, and brain-computer interfaces, with an emphasis on addressing industry challenges like neurocritical care and functional disorder rehabilitation. However, both sectors commonly face pain points such as the “disconnection between clinical needs and engineering R&D” and “sluggish supply chain responsiveness,” resulting in insufficient product adaptability and low innovation conversion efficiency, which hinder high-quality industry development.
This forum, anchored by the theme “Unlocking Core Hospital Needs,” focuses on innovative pathways and supply chain optimization solutions in the cardiovascular and neurological clinical fields. Its goal is to facilitate the precise implementation of medical-engineering achievements, optimize the allocation of medical resources, and comprehensively elevate the diagnostic and treatment standards in cardiovascular and neurological care.
Participants:
- Medical device manufacturers: R&D, design, process departments, and project/corporate leaders
- Related equipment suppliers and service providers
- Clinicians, universities and research institutes
- Other interested professionals
Agenda:
| Time | Topic |
| 13:20-13:30 | Moderator Remarks |
| 13:30-15:00 Cardiovascular Session (Electrophysiology) | |
| 13:30-14:00 | Hospital End: Pain Points and Demand Sharing in Clinical Electrophysiological Diagnosis and Treatment |
| 14:00-14:30 | Equipment Manufacturers: R&D Innovation and Product Iteration Paths for Electrophysiological Devices & Consumables Against the Backdrop of Volume-based Procurement |
| 14:30-15:00 | Supply Chain Enterprises: Whole-Chain Synergy of Electrophysiological Products: Empowering Clinics and Finished Product Manufacturers |
| 15:00-16:30 Neurology Session (Neurointervention) | |
| 15:00-15:30 | Hospital End: Unmet Clinical Needs and Pain Points in Neurointerventional Therapy |
| 15:30-16:00 | Equipment Manufacturers: Localization of Neurointerventional Devices: From Clinical Demands to Product Implementation |
| 16:00-16:30 | Supply Chain Companies: Precision Manufacturing and Quality Control of Core Components for Neurointerventional Devices |
| 16:30-16:40 | Conference Close |